# AbbVie Inc.: Form 8-K, filed Oct 30, 2026

- Company: [AbbVie Inc.](/companies/abbv.md) (CIK 1551152)
- Form: 8-K
- Filed: 2026-10-30
- Accepted by EDGAR: Oct 30, 2026, 07:51 ET
- Period: 2026-10-30
- Accession: 0001551152-26-000033
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000033/abbv-20261030.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1551152/000155115226000033/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1551152/000155115226000033/abbv-20261030.htm

Filed Oct 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001551152-26-000033. Last ingested by Listed: Nov 13, 2026, 16:34 ET. No prices; not investment advice.
